Most physicians don’t support a shift away from the fee-for-service model. Do you agree? Or is bundled payments and incentives the path forward?
Most physicians don’t support a shift away from the fee-for-service model. They aren’t fans of bundled payments, and don’t want to take steps to add incentives in the system.
That’s according to a recent Journal of the American Medical Association survey. This is the same survey that found that physicians think others in the industry - trial lawyers, insurance companies, hospitals, device manufacturers and patients - bear a greater burden for lowering healthcare costs.
When it comes to payment reform:[[{"type":"media","view_mode":"media_crop","fid":"15746","attributes":{"alt":"","class":"media-image media-image-right","id":"media_crop_5353937962756","media_crop_h":"0","media_crop_image_style":"-1","media_crop_instance":"808","media_crop_rotate":"0","media_crop_scale_h":"0","media_crop_scale_w":"0","media_crop_w":"0","media_crop_x":"0","media_crop_y":"0","style":"float: right; margin: 5px;","title":" ","typeof":"foaf:Image"}}]]
Do you agree? Are you opposed to the shift away from fee-for-service? Or is bundled payments the ideal path forward?
Please tell us what you think in the comments field below.
Where Things Stand with the Radiologist Shortage
June 18th 2025A new report conveys the cumulative impact of ongoing challenges with radiologist residency positions, reimbursement, post-COVID-19 attrition rates and the aging of the population upon the persistent shortage of radiologists in the United States.
How to Successfully Launch a CCTA Program at Your Hospital or Practice
June 11th 2025Emphasizing increasing recognition of the capability of coronary computed tomography angiography (CCTA) for the evaluation of acute and stable chest pain, this author defuses common misperceptions and reviews key considerations for implementation of a CCTA program.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Mammography AI Platform for Five-Year Breast Cancer Risk Prediction Gets FDA De Novo Authorization
June 2nd 2025Through AI recognition of subtle patterns in breast tissue on screening mammograms, the Clairity Breast software reportedly provides validated risk scoring for predicting one’s five-year risk of breast cancer.